Home › Sovrappeso › California
Studi clinici su Sovrappeso nello stato di California
64 studi su Sovrappeso cercano partecipanti presso sedi nello stato di California.
Città nello stato di California
- Concord16 studi
- Los Angeles15 studi
- San Diego13 studi
- Escondido12 studi
- El Cajon9 studi
- Torrance9 studi
- Santa Ana7 studi
- Tustin7 studi
- Sacramento6 studi
- Long Beach5 studi
- Santa Clarita5 studi
- Huntington Beach5 studi
- Santa Monica5 studi
- Indio5 studi
- South Gate5 studi
- Lake Forest4 studi
- Richmond4 studi
- Westminster4 studi
- Simi Valley4 studi
- Hawthorne4 studi
- Chula Vista4 studi
- Ontario3 studi
- Riverside3 studi
- West Covina3 studi
- Glendale3 studi
Testo ufficiale dello studio (inglese)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- John Muir Health - Concord /ID# 282469, Concord
- NorCal Medical Research /ID# 283117, Greenbrae
- Velocity Clinical Research - Huntington Park /ID# 282987, Huntington Park
- e altri 6
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07752979A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
- ProSciento, INC, Chula Vista
In reclutamentoFase 1Volontari sani benvenuti
Età da 18 a 70 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07675590Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
- Cedars Sinai Medical Center, Los Angeles
In reclutamento
Età da 21 a 65 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07090005AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- Torrance Clinical Research Institute, Inc., Lomita
- Diablo Clinical Research, Inc., Walnut Creek
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Neighborhood Healthcare, Escondido
In reclutamentoFase 3
Età da 8 a 18 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07253285Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Diablo Clinical Research - Flourish Research, Walnut Creek
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07685808Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- Profound Research, Oceanside
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07837973AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Providence Medical Foundation, Fullerton
- Torrance Clinical Research Institute, Inc., Lomita
- Diablo Clinical Research, Inc., Walnut Creek
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- First Valley Medical Group, Lancaster
- Desert Oasis Healthcare, Palm Springs
- Western University of Health Sciences, Pomona
- e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07668414A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Orange County Research Center, Lake Forest
- Healthy Brain Clinic, Long Beach
- Los Angeles Institute for Metabolic Research, Los Angeles
- e altri 6
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Headlands Research California, LLC, Escondido
- ImmuniMet, LLC, Modesto
- e altri 4
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Escondido
- Research Site, Lincoln
- Research Site, Walnut Creek
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07776509Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
- Parexel International, Glendale
In reclutamentoFase 1Volontari sani benvenuti
Età da 18 a 65 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07594093Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- e altri 1
In reclutamentoFase 3
Età da 18 a 70 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Loma Linda University School of Medicine, Loma Linda
- Childrens Hospital of Los Angeles, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
- e altri 2
In reclutamentoFase 3
Età da 6 a 17 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- e altri 1
In reclutamentoFase 3
Età da 18 a 70 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- San Fernando Valley Health Institute, Canoga Park
- AMCR Institute, Escondido
- NorCal Medical Research, Inc, Greenbrae
- e altri 6
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Irvine Clinical Research, Irvine
- Scripps Whittier Diabetes Institute, La Jolla
- EndoTrials Center for Clinical Research, La Mesa
- e altri 5
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07392190A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Bakersfield
- Research Site, Gardena
- Research Site, Lincoln
- e altri 2
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Ark Clinical Research, Long Beach
- Collaborative Neuroscience Research, LLC, Los Alamitos
- Artemis Institute for Clinical Research, Riverside
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07369011CHOICE to AVOID or RESIST
- Cedars-Sinai Medical Center, Beverly Hills
In reclutamentoVolontari sani benvenuti
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06521021Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Valley Clinical Trials, LLC dba Flourish Research, Covina
- Velocity Clinical Research- Huntington Park, Huntington Park
- Orange County Research Center, Lake Forest
- e altri 5
In reclutamentoFase 3
Età da 45 a 99 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Neighborhood Healthcare Institute of Health, Escondido
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Desert Oasis Healthcare Medical Group, Palm Springs
- e altri 4
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07321886Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Wolverine Clinical Trials, Santa Ana
- Encompass Clinical Research, Spring Valley
- e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07353931A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- NorCal Medical Research, Inc, Greenbrae
- Velocity Clinical Research, Huntington Park, Huntington Park
- Peninsula Research Associates, Rolling Hills Estates
- e altri 1
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07589608A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
- Research Site, Glendale
In reclutamentoFase 1Volontari sani benvenuti
Età da 35 a 75 · Donne · Aggiornato il 17 set 2026 · NCT07013643A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Banning
- AURORA-1 Clinical Site, Chula Vista
- AURORA-1 Clinical Site, Covina
- e altri 5
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Banning
- AURORA-2 Clinical Site, Chula Vista
- AURORA-2 Clinical Site, Covina
- e altri 6
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Orange County Research Center, Lake Forest
- Ark Clinical Research, Long Beach
- Catalina Research Institute, LLC, Montclair
- e altri 3
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Wolverine Clinical Trials, Santa Ana
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 14 set 2026 · NCT06897475A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- University of California Irvine, Irvine
- Artemis Institute for Clinical Research, LLC, San Diego
- Diablo Clinical Research, Inc., Walnut Creek
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07351045AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Artemis Insitute for Clin Res, San Diego
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 set 2026 · NCT07571005A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Escondido
- ACCOMPLISH-2 Research Site, Fountain Valley
- ACCOMPLISH-2 Research Site, La Jolla
- e altri 4
In reclutamentoFase 3Volontari sani benvenuti
Età da 18 a 79 · Tutti i sessi · Aggiornato il 11 set 2026 · NCT07654374A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
- PAREXEL Glendale/LA EPCU, Glendale
In reclutamentoFase 1
Età da 18 a 55 · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07566390Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Headlands Research California, LLC, Escondido
- National Research Institute - Huntington Park, Huntington Park
- Los Angeles Institute for Metabolic Research, Los Angeles
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07770841Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication
- UCLA Center for Human Nutrition, Los Angeles
In reclutamentoVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07806838A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- NorCal Medical Research, Inc, Greenbrae
- Velocity Clinical Research, Huntington Park, Huntington Park
- Peninsula Research Associates, Rolling Hills Estates
- e altri 1
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06143956A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- First OC Dermatology Research Inc, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Metropolis Dermatology, Los Angeles
- e altri 1
In reclutamentoFase 4
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Escondido
- Kailera Clinical Site, La Mesa
- Kailera Clinical Site, Montclair
- e altri 3
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Ark Clinical Research- Tustin, Fountain Valley
- Long Beach Clinical Trials Services Inc, Long Beach
- Ark Clinical Research- Long Beach, Long Beach
- e altri 6
In reclutamentoFase 3
Età da 18 a 99 · Tutti i sessi · Aggiornato il 3 set 2026 · NCT07684235Fonte: ClinicalTrials.gov, dati recuperati il 3 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.